Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
Journal of Clinical Medicine · 11.11.2023 · 12 (22) · 7041
DOI: 10.3390/jcm12227041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.11.2023. Verfasst von Marco Sebastiani und 16 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Azienda Policlinico di Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer-Ingelheim.
Abstract (Originalsprache)
Background
The INBUILD study demonstrated the efficacy of nintedanib in the treatment of progressive fibrosing interstitial lung disease different to idiopathic pulmonary fibrosis, including rheumatoid arthritis (RA)-related ILD. Nevertheless, the prevalence of RA-ILD patients that may potentially benefit from nintedanib remains unknown. Objectives and methods: The aim of the present multicentre study was to investigate the prevalence and possible associated factors of fibrosing progressive patterns in a cross-sectional cohort of RA-ILD patients.
Results
One hundred and thirty-four RA-ILD patients with a diagnosis of RA-ILD, who were confirmed at high-resolution computed tomography and with a follow-up of at least 24 months, were enrolled. The patients were defined as having a progressive fibrosing ILD in case of a relative decline in forced vital capacity > 10% predicted and/or an increased extent of fibrotic changes on chest imaging in a 24-month period. Respiratory symptoms were excluded to reduce possible bias due to the retrospective interpretation of cough and dyspnea. According to radiologic features, ILD was classified as usual interstitial pneumonia (UIP) in 50.7% of patients, nonspecific interstitial pneumonia in 19.4%, and other patterns in 29.8%. Globally, a fibrosing progressive pattern was recorded in 36.6% of patients (48.5% of patients with a fibrosing pattern) with a significant association to the UIP pattern.
Conclusion
We observed that more than a third of RA-ILD patients showed a fibrosing progressive pattern and might benefit from antifibrotic treatment. This study shows some limitations, such as the retrospective design. The exclusion of respiratory symptoms’ evaluation might underestimate the prevalence of progressive lung disease but increases the value of results.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology Unit, Azienda Policlinico di Modena, University of Modena and Reggio Emilia, 41121 Modena, Italy.
- Rheumatology Unit, Department of Precision and Regenerative Medicine-Ionian Area, University of Bari "Aldo Moro", 70121 Bari, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
- Rheumatology Unit, Azienda Ospedaliero-Universitaria Senese, Università Degli Studi di Siena, 53100 Siena, Italy.
- Rheumatology Unit, University of Messina, 98122 Messina, Italy.
- Rheumatology Unit, Azienda Ospedaliera San Camillo Forlanini, 00152 Roma, Italy.
ORCID-Profile: Marco Sebastiani, Vincenzo Venerito, Dario Andrisani, Giulia Cassone, Florenzo Iannone
Förderung
- Boehringer-Ingelheim
Zitieren
APA
Sebastiani, M., Venerito, V., Laurino, E., Gentileschi, S., Atzeni, F., Canofari, C., Andrisani, D., Cassone, G., Lavista, M., D'Alessandro, F., Vacchi, C., Scardapane, A., Frediani, B., Cazzato, M., Salvarani, C., Iannone, F., & Manfredi, A. (2023). Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study. Journal of Clinical Medicine, 12(22), 7041. https://doi.org/10.3390/jcm12227041
Vancouver
Sebastiani M, Venerito V, Laurino E, Gentileschi S, Atzeni F, Canofari C, et al. Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study. Journal of Clinical Medicine. 2023;12(22):7041. doi:10.3390/jcm12227041
BibTeX
@article{Sebastiani2023,
author = {Sebastiani, Marco and Venerito, Vincenzo and Laurino, Elenia and Gentileschi, Stefano and Atzeni, Fabiola and Canofari, Claudia and Andrisani, Dario and Cassone, Giulia and Lavista, Marlea and D'Alessandro, Francesco and Vacchi, Caterina and Scardapane, Arnaldo and Frediani, Bruno and Cazzato, Massimiliano and Salvarani, Carlo and Iannone, Florenzo and Manfredi, Andreina},
title = {Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {22},
pages = {7041},
doi = {10.3390/jcm12227041}
}
EUVIMED